SCHEMBL30459905

SCHEMBL30459905

COC(=O)c1cc(CO)ncc1Nc1ccc([Si](C)(C)C)cc1F

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP2K1 Q02750 5/20 0.35
▸ DHODH Q02127 4/20 0.35
▸ MAPK14 Q16539 2/20 0.34
▸ MAPK13 O15264 1/20 0.34
▸ CSF1R P07333 3/20 0.33
▸ TGFBR1 P36897 1/20 0.33
▸ MAP2K2 P36507 1/20 0.33
▸ PRKCZ Q05513 1/20 0.33
▸ IARS2 Q9NSE4 1/20 0.33
▸ NUDT1 P36639 2/20 0.33
▸ CA12 O43570 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ CA3 P07451 1/20 0.33
▸ CA6 P23280 1/20 0.33
▸ CA5A P35218 1/20 0.33
▸ CA7 P43166 1/20 0.33
▸ CA9 Q16790 1/20 0.33
▸ CA14 Q9ULX7 1/20 0.33
▸ CA5B Q9Y2D0 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23673990 1.00 MAP2K1 (0.35) MAP2K1DHODHMAPK14MAPK13CSF1R
SCHEMBL23673873 0.90 MAP2K1 (0.35) MAP2K1DHODHMAPK14MAPK13CSF1R
SCHEMBL30866576 0.89 DHODH (0.37) MAP2K1DHODHMAP2K2KDM4E
SCHEMBL23673877 0.85 MAP2K1 (0.37) MAP2K1DHODHMAPK14MAPK13CSF1R
SCHEMBL23673984 0.84 KDM4E (0.43) MAP2K1DHODHMAPK14CSF1RKDM4E
SCHEMBL29425395 0.84 KDM4E (0.43) MAP2K1DHODHMAPK14CSF1RKDM4E
SCHEMBL24848964 0.83 DHODH (0.36) MAP2K1DHODHCSF1RTGFBR1MAP2K2
SCHEMBL29425398 0.82 MAPK14 (0.34) MAP2K1DHODHMAPK14MAPK13CSF1R
SCHEMBL23673897 0.82 MAPK14 (0.34) MAP2K1DHODHMAPK14MAPK13CSF1R
SCHEMBL29781364 0.82 MAPK14 (0.34) MAP2K1DHODHMAPK14MAPK13CSF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4725941-A1 ARYLAMIDE DERIVATIVE HAVING ANTITUMOR ACTIVITY CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2026-04-15 — — EP disclosed
EP-4375273-A1 METHOD FOR PRODUCING ARYLAMIDE DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2024-05-29 — — EP disclosed
EP-4186506-A1 COMPOSITION CONTAINING ARYLAMIDE DERIVATIVE CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2023-05-31 — — EP disclosed
Send feedback